SREBPs: Metabolic integrators in physiology and metabolism

Trends in Endocrinology and Metabolism

Volumn 23, Issue 2, 2012, Pages 65-72

  Jeon, Tae Il ^a   Osborne, Timothy F ^b  

^a Korea Food Research Institute   (South Korea)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER X RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

5' UNTRANSLATED REGION; ADIPOSE DERIVED STEM CELL; ATHEROSCLEROSIS; AUTOPHAGY; AUTOREGULATION; CELL TRANSFORMATION; CHOLESTEROL SYNTHESIS; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME REGULATION; EXON; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLIOBLASTOMA; GLUCOSE METABOLISM; HYPOTHALAMUS; IN VIVO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIPID STORAGE; LIPOGENESIS; LIPOPHAGOCYTOSIS; LIVER; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; STEATOSIS; TISSUE DISTRIBUTION; UNFOLDED PROTEIN RESPONSE;

ANIMALS; AUTOPHAGY; CELL NUCLEUS; HUMANS; IMMUNITY, INNATE; LIPID METABOLISM; LIVER; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROL REGULATORY ELEMENT BINDING PROTEINS; SULFOTRANSFERASES; UNFOLDED PROTEIN RESPONSE;

EID: 84856471735     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.10.004     Document Type: Review

References (76)

1. Osborne T.F., Espenshade P.J. Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been. Genes Dev. 2009, 23:2578-2591.
2. Horton J.D., et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109:1125-1131.
3. Amemiya-Kudo M., et al. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J. Biol. Chem. 2000, 275:31078-31085.
4. Chen G., et al. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11245-11250.
5. Repa J.J., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 2000, 14:2819-2830.
6. Chen W., et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 2007, 5:73-79.
7. Im S.S., et al. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 2011, 13:540-549.
8. Sato R., et al. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 1996, 26461-26464.
9. Shin D.J., Osborne T.F. Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J. Biol. Chem. 2003, 278:34114-34118.
10. Suzuki R., et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab. 2010, 12:567-579.
11. Marquart T.J., et al. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12228-12232.
12. Rayner K.J., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
13. Najafi-Shoushtari S.H., et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
14. Horie T., et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:17321-17326.
15. Gerin I., et al. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J. Biol. Chem. 2010, 285:33652-33661.
16. Davalos A., et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9232-9237.
17. Hua X., et al. Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane. J. Biol. Chem. 1996, 271:10379-10384.
18. Hannah V.C., et al. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 2001, 276:4365-4372.
19. Engelking L.J., et al. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J. Clin. Invest. 2004, 113:1168-1175.
20. Engelking L.J., et al. Schoenheimer effect explained - feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. J. Clin. Invest. 2005, 115:2489-2498.
21. Horton J.D., et al. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 1998, 101:2331-2339.
22. Horton J.D., et al. Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J. Biol. Chem. 2003, 278:36652-36660.
23. Korn B.S., et al. Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N). J. Clin. Invest. 1998, 102:2050-2060.
24. Shimano H., et al. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 1996, 98:1575-1584.
25. Shimano H., et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 1999, 274:35832-35839.
26. Bennett M.K., et al. Selective binding of srebp isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver. J. Biol. Chem. 2008, 283:15628-15637.
27. Sheng Z., et al. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:935-938.
28. Horton J.D., et al. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5987-5992.
29. Seo Y.K., et al. Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy. Cell Metab. 2011, 13:367-375.
30. Gurcel L., et al. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006, 126:1135-1145.
31. Hegarty B.D., et al. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:791-796.
32. Lee J.N., Ye J. Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J. Biol. Chem. 2004, 279:45257-45265.
33. Du X., et al. Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol. Biol. Cell 2006, 17:2735-2745.
34. Foretz M., et al. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glukokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:12737-12742.
35. Yellaturu C.R., et al. Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles. J. Biol. Chem. 2009, 284:7518-7532.
36. Li S., et al. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3441-3446.
37. Krycer J.R., et al. The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol. Metab. 2010, 21:268-276.
38. Porstmann T., et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008, 8:224-236.
39. Cheadle J.P., et al. Molecular genetic advances in tuberous sclerosis. Hum. Genet. 2000, 107:97-114.
40. Duvel K., et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 2010, 39:171-183.
41. Peterson T.R., et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011, 146:408-420.
42. Finck B.N., et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 2006, 4:199-210.
43. Huffman T.A., et al. Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1047-1052.
44. Ishimoto K., et al. Sterol-mediated regulation of human lipin 1 gene expression in hepatoblastoma cells. J. Biol. Chem. 2009, 284:22195-22205.
45. Seo Y.K., et al. Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13765-13769.
46. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114:147-152.
47. Shimano H., et al. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 1997, 99:846-854.
48. Shimomura I.Y.B., Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 1999, 274:30028-30032.
49. Leavens K.F., et al. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 2009, 10:405-418.
50. Brown M.S., Goldstein J.L. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 2008, 7:95-96.
51. Biddinger S.B., et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008, 7:125-134.
52. Yecies J.L., et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011, 14:21-32.
53. Hsu P.P., et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332:1317-1322.
54. Um S.H., et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004, 431:200-205.
55. Yu Y., et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011, 332:1322-1326.
56. Yabe D., et al. Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3155-3160.
57. Wander S.A., et al. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J. Clin. Invest. 2011, 121:1231-1241.
58. Shimano H., et al. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J. Clin. Invest. 1997, 100:2115-2124.
59. Kuhajda F.P. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000, 16:202-208.
60. Kuhajda F.P., et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:6379-6383.
61. Bennett M.K., et al. Sterol regulation of fatty acid synthase promoter: coordinate feedback regulation of two major lipid pathways. J. Biol. Chem. 1995, 270:25578-25583.
62. Guo D., et al. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci. Signal. 2009, 2:ra82.
63. Cloughesy T.F., et al. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med. 2008, 5:e8.
64. Rutkowski D.T., et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev. Cell 2008, 15:829-840.
65. Singh R., et al. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
66. Yang L., et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010, 11:467-478.
67. Castoreno A.B., et al. Transcriptional regulation of phagocytosis-induced membrane biogenesis by sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13129-13134.
68. Franchi L., et al. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009, 10:241-247.
69. Weichhart T., et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 2008, 29:565-577.
70. Dazert E., Hall M.N. mTOR signaling in disease. Curr. Opin. Cell Biol. 2011, 10.1016/j.ceb.2011.09.003.
71. Blanc M., et al. host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol. 2011, 9:e1000598.
72. Ecker J., et al. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7817-7822.
73. Li Y., et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011, 13:376-388.
74. Gwinn D.M., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 2008, 30:214-226.
75. Hughes A.L., et al. SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell 2005, 120:831-842.
76. Jeon T.I., et al. SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice. J. Clin. Invest. 2008, 118:3693-3700.